Android app Apple app link

Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected

By Yahoo! Finance   |   1 week ago
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected

Investors in GLP-1 medications have not seen expected gains despite the popularity of weight-loss drugs. ETFs like HRTS, OZEM, and THNR have underperformed due to volatile markets and high expense ratios.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.